Results 111 to 120 of about 11,650 (154)
Some of the next articles are maybe not open access.
Biochemical and Biophysical Research Communications, 2023
Reticular dysgenesis (RD) is a rare genetic disease caused by gene mutations in the ATP:AMP phosphotransferase, adenylate kinase 2 (AK2). Patients with RD suffer from severe combined immunodeficiency with neutrophil maturation arrest.
Ayako Tanimura +2 more
exaly +2 more sources
Reticular dysgenesis (RD) is a rare genetic disease caused by gene mutations in the ATP:AMP phosphotransferase, adenylate kinase 2 (AK2). Patients with RD suffer from severe combined immunodeficiency with neutrophil maturation arrest.
Ayako Tanimura +2 more
exaly +2 more sources
Cancer Research, 2023
Aryl hydrocarbon receptor(AhR) is a ligand-dependent transcription factor that regulates the activity of innate and adaptive immune cells subsequent to binding of numerous endogenous and exogenous ligands.
D. Cha +10 more
semanticscholar +1 more source
Aryl hydrocarbon receptor(AhR) is a ligand-dependent transcription factor that regulates the activity of innate and adaptive immune cells subsequent to binding of numerous endogenous and exogenous ligands.
D. Cha +10 more
semanticscholar +1 more source
The China Quarterly, 2022
disputes. The author analyses the major cases, focusing on the issues raised, the tribunals’ interpretations and the implications of the rulings. Shen Wei opens each chapter by setting the stage thematically for the detailed discussion that follows ...
Zinian Zhang
semanticscholar +1 more source
disputes. The author analyses the major cases, focusing on the issues raised, the tribunals’ interpretations and the implications of the rulings. Shen Wei opens each chapter by setting the stage thematically for the detailed discussion that follows ...
Zinian Zhang
semanticscholar +1 more source
Cancer Research, 2022
Introduction TGFβ is an immunoregulatory cytokine that can function as an oncogenic factor to mediate tumorigenesis, metastasis, and immune escape. Recent studies have shown that TGFβ can drive immune-excluded phenotype in tumor microenvironment (TME ...
R. Pomponio +12 more
semanticscholar +1 more source
Introduction TGFβ is an immunoregulatory cytokine that can function as an oncogenic factor to mediate tumorigenesis, metastasis, and immune escape. Recent studies have shown that TGFβ can drive immune-excluded phenotype in tumor microenvironment (TME ...
R. Pomponio +12 more
semanticscholar +1 more source
Tumor Biology, 2020
Proceedings: AACR Annual Meeting 2020; April 27-28, 2020 and June 22-24, 2020; Philadelphia, PA Tumor-associated fibroblasts (TAFs) exhibit an activated/fibrotic phenotype in all subtypes of non-small cell lung cancer.
Marta Gabasa +6 more
semanticscholar +1 more source
Proceedings: AACR Annual Meeting 2020; April 27-28, 2020 and June 22-24, 2020; Philadelphia, PA Tumor-associated fibroblasts (TAFs) exhibit an activated/fibrotic phenotype in all subtypes of non-small cell lung cancer.
Marta Gabasa +6 more
semanticscholar +1 more source
Cancer Research
Multiple myeloma (MM) remains incurable due to disease relapses, thought to stem from the activation of dormant MM cells. Preventing the awakening or eliminating dormant MM cells is crucial to avoiding disease relapse.
H. Sabol +12 more
semanticscholar +1 more source
Multiple myeloma (MM) remains incurable due to disease relapses, thought to stem from the activation of dormant MM cells. Preventing the awakening or eliminating dormant MM cells is crucial to avoiding disease relapse.
H. Sabol +12 more
semanticscholar +1 more source
Advancement of science
Obesity underlies metabolic dysfunction and contributes to the pathogenesis of various diseases. Obesity associated adipose tissue (AT) inflammation contributes to whole body inflammation vulnerability and metabolic disease development.
Ping Tang +9 more
semanticscholar +1 more source
Obesity underlies metabolic dysfunction and contributes to the pathogenesis of various diseases. Obesity associated adipose tissue (AT) inflammation contributes to whole body inflammation vulnerability and metabolic disease development.
Ping Tang +9 more
semanticscholar +1 more source
Cancer Research
Background: PD-L1 expression drives anti-PD(L)-1 treatment decisions across many cancer indications. FGFR inhibitors have been approved for the treatment of metastatic urothelial cancer (UC) and cholangiocarcinoma with FGFR alts. BALVERSA (erdafitinib),
Min Qing +7 more
semanticscholar +1 more source
Background: PD-L1 expression drives anti-PD(L)-1 treatment decisions across many cancer indications. FGFR inhibitors have been approved for the treatment of metastatic urothelial cancer (UC) and cholangiocarcinoma with FGFR alts. BALVERSA (erdafitinib),
Min Qing +7 more
semanticscholar +1 more source

